The tensions facing the global supply chain have been building in the pharmaceutical industry since even before the pandemic began, said Apurva Saraf, CEO of privately-held Cosette Pharmaceuticals (South Plainfield, New Jersey), in a recent interview. About five years ago, China, a central producer of active pharmaceutical ingredients (APIs), began shutting down tens of thousands…